138 related articles for article (PubMed ID: 8606636)
1. Differential beta-cell response to glucose, glucagon, and arginine during progression to type I (insulin-dependent) diabetes mellitus.
Chaillous L; Rohmer V; Maugendre D; Lecomte P; Maréchaud R; Marre M; Guilhem I; Charbonnel B; Saï P
Metabolism; 1996 Mar; 45(3):306-14. PubMed ID: 8606636
[TBL] [Abstract][Full Text] [Related]
2. Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study.
Greenbaum CJ; Sears KL; Kahn SE; Palmer JP
Diabetes; 1999 Jan; 48(1):170-5. PubMed ID: 9892239
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of age-related acute insulin response to glucose in subjects at risk for type 1 diabetes: results of a 6-year follow-up study from west-France.
Bardet S; Joseph MG; Maugendre D; Matthieu E; Chaillous L; Semana G; Limal JM; Allannic H; Charbonnel B; Sai P
Diabete Metab; 1993; 19(4):372-80. PubMed ID: 8293864
[TBL] [Abstract][Full Text] [Related]
4. Acute insulin response to intravenous glucose, glucagon and arginine in some subjects at risk for type 1 (insulin-dependent) diabetes mellitus.
Bardet S; Rohmer V; Maugendre D; Marre M; Semana G; Limal JM; Allannic H; Charbonnel B; Saï P
Diabetologia; 1991 Sep; 34(9):648-54. PubMed ID: 1955097
[TBL] [Abstract][Full Text] [Related]
5. Differential sensitivity to beta-cell secretagogues in "early," type I diabetes mellitus.
Ganda OP; Srikanta S; Brink SJ; Morris MA; Gleason RE; Soeldner JS; Eisenbarth GS
Diabetes; 1984 Jun; 33(6):516-21. PubMed ID: 6373458
[TBL] [Abstract][Full Text] [Related]
6. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?
Schatz D; Cuthbertson D; Atkinson M; Salzler MC; Winter W; Muir A; Silverstein J; Cook R; Maclaren N; She JX; Greenbaum C; Krischer J
Pediatr Diabetes; 2004 Jun; 5(2):72-9. PubMed ID: 15189492
[TBL] [Abstract][Full Text] [Related]
7. B-cell responses to intravenous glucose and glucagon in non-diabetic twins of patients with type 1 (insulin-dependent) diabetes mellitus.
Heaton DA; Lazarus NR; Pyke DA; Leslie RD
Diabetologia; 1989 Nov; 32(11):814-7. PubMed ID: 2687066
[TBL] [Abstract][Full Text] [Related]
8. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
Greenbaum CJ; Prigeon RL; D'Alessio DA
Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
[TBL] [Abstract][Full Text] [Related]
9. Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study.
McCulloch DK; Klaff LJ; Kahn SE; Schoenfeld SL; Greenbaum CJ; Mauseth RS; Benson EA; Nepom GT; Shewey L; Palmer JP
Diabetes; 1990 May; 39(5):549-56. PubMed ID: 2185106
[TBL] [Abstract][Full Text] [Related]
10. [A study of the degrees of insulin resistance and first-phase insulin secretion of beta-cells in metabolic syndrome patients with different glucose tolerance].
Hong J; Gu WQ; Zhang YF; Guo Y; Chen HM; Zhang LZ; Zhao YJ; Ning G
Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(22):1952-6. PubMed ID: 14703429
[TBL] [Abstract][Full Text] [Related]
11. Impact of family history of diabetes on the assessment of beta-cell function.
Alford FP; Henriksen JE; Rantzau C; Vaag A; Hew LF; Ward GM; Beck-Nielsen H
Metabolism; 1998 May; 47(5):522-8. PubMed ID: 9591741
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients.
Vardi P; Crisa L; Jackson RA
Diabetologia; 1991 Feb; 34(2):93-102. PubMed ID: 2065854
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin A does not delay insulin dependency in asymptomatic IDDM patients.
Rakotoambinina B; Timsit J; Deschamps I; Laborde K; Jos J; Boitard C; Assan R; Robert JJ
Diabetes Care; 1995 Nov; 18(11):1487-90. PubMed ID: 8722075
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance.
Byrne MM; Gliem K; Wank U; Arnold R; Katschinski M; Polonsky KS; Göke B
Diabetes; 1998 Aug; 47(8):1259-65. PubMed ID: 9703326
[TBL] [Abstract][Full Text] [Related]
15. Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.
Palmer JP; Benson JW; Walter RM; Ensinck JW
J Clin Invest; 1976 Sep; 58(3):565-70. PubMed ID: 783201
[TBL] [Abstract][Full Text] [Related]
16. [Decrease of early insulin secretion, risk factor of insulin-dependent diabetes. Prospective study in families with diabetic children].
Robert JJ; Boitard C; Mogenet A; Chevenne D; Roger M; Deschamps I
Arch Fr Pediatr; 1991 Jan; 48(1):11-7. PubMed ID: 2018414
[TBL] [Abstract][Full Text] [Related]
17. Altered islet beta-cell function before the onset of type 1 (insulin-dependent) diabetes mellitus.
Lo SS; Hawa M; Beer SF; Pyke DA; Leslie RD
Diabetologia; 1992 Mar; 35(3):277-82. PubMed ID: 1563585
[TBL] [Abstract][Full Text] [Related]
18. AIRarg and AIRgluc as predictors of insulin secretory reserve.
Robertson RP
Transplant Proc; 2004 May; 36(4):1040-1. PubMed ID: 15194361
[TBL] [Abstract][Full Text] [Related]
19. Insulin responses to intravenous glucose, intravenous arginine and a hyperglycaemic clamp in ICA-positive subjects with different degrees of glucose tolerance.
Rakotoambinina B; Timsit J; Deschamps I; Laborde K; Gautier D; Jos J; Boitard C; Robert JJ
Diabetes Metab; 1997 Feb; 23(1):43-50. PubMed ID: 9059765
[TBL] [Abstract][Full Text] [Related]
20. Diminished A-cell secretion in the early phase of type I diabetes mellitus.
Ganda OP; Srikanta S; Gleason RE; Soeldner JS; Eisenbarth GS
Metabolism; 1986 Nov; 35(11):1074-7. PubMed ID: 3534518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
